RG
Insider
Robert E. Gagnon
Chief Financial OfficerRobert E. Gagnon (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Opus Genetics, Inc. (IRD). The largest single filing was $127K of IRD (28,000 sh × $4.54, as filed), executed Sep 3.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$127K
shares × price, as filed
Last traded
Sep 3
Filed Sep 8
Median ADV $4.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $127K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
IRD
Opus Genetics, Inc.
IRD · 0 buys · 1 sell
1 filing
Recent filings
IRDSALE
Opus Genetics, Inc.
View filing →
$127K28,000 sh × $4.54
Exec Sep 3
Filed Sep 8 · 4:05 PM ET